Analysis Of Market Structure And Competitive Dynamics Of Major Manufacturers

Analysis of Market Structure and Competitive Dynamics of Major Manufacturers
The laparoscopic cannula, as the core instrument for minimally invasive surgical procedures, has a market landscape in 2025 characterized by "domination by international giants and the rise of local enterprises". According to the research data from ResearchAndMarkets.com, the global market size of laparoscopic cannula needles in 2025 was 5.904 billion yuan (RMB), with the domestic market size being 1.932 billion yuan. It is expected that the global market size will reach 9.12 billion yuan by 2032, with a compound annual growth rate (CAGR) of 6.41% from 2025 to 2032. This growth is mainly attributed to the continuous increase in the penetration rate of minimally invasive surgeries, the trend of population aging, and the surge in demand for chronic disease management.
From the perspective of the global competitive landscape, the market is mainly dominated by international medical giants. Multinational enterprises such as Applied Medical, Genicon, Conmed, J&J (Ethicon), KARL STORZ, Olympus, and Medtronic constitute the main players in the industry. These enterprises, with their strong R&D capabilities, complete product lines, and mature global sales networks, have significant advantages in the high-end laparoscopic cannula market. Particularly in the high-end product fields such as visual puncture devices and bladeless design, the technological leadership of multinational enterprises is more prominent.
The market for disposable laparoscopic cannulas also exhibits a concentrated feature. According to the research by DIResearch, the global market for disposable laparoscopic cannulas will reach 2.08 billion US dollars by 2025, and is expected to reach 4.189 billion US dollars by 2032, with an annual compound growth rate (CAGR) of 10.52%. The leading companies in the global disposable laparoscopic cannula market include Johnson & Johnson (Ethicon), Medtronic, Applied Medical, B. Braun, Conmed, Purple Surgical, Genicon, Ackermann, etc.
In the Chinese market, the process of domestic substitution is accelerating. Local enterprises such as Guangzhou Dike Medical Devices, Guangdian Medical, Shubeikang, Victor Medical, etc., have been expanding their market share through technological upgrades and large-scale production. The leading enterprises in the Chinese laparoscopic cannula needle industry include Medtronic, J&J (Ethicon), Applied Medical, B.Braun, Genicon, Olympus, and KARL STORZ. These companies have established their own competitive advantages in different market segments.
From the perspective of product structure, laparoscopic cannulas are mainly divided into specifications such as 12mm, 15mm, 5mm, and 10mm. Among them, the three mainstream specifications of 5mm, 10mm, and 12mm occupy a dominant position in the market, accounting for 38.2%, 45.6%, and 16.2% of the share respectively. The share of disposable products has continued to increase due to their advantages in infection control, and is expected to exceed 92% in 2030.
In terms of application areas, the downstream applications of laparoscopic cannulas cover multiple fields such as general surgery, weight loss surgery, urology, and gynecology. Among them, general surgery and gynecology are the largest application markets, which is closely related to the popularity of minimally invasive surgeries in these fields.
The regional market distribution shows that the global market exhibits significant regional differences. Over 40% of the markets are concentrated in North America, Europe accounts for 28%, the Asia-Pacific region accounts for 22%, and the Middle East and Africa contribute 10%. The disposable laparoscopic cannula market in the United States is expected to account for nearly 33% of the global share by 2025. The Chinese market, as the world's largest emerging market, not only has a rapidly growing market size but also continuously enhances its technological innovation capabilities.
Price competition has become increasingly fierce with the implementation of the volume-based procurement policy. In November 2025, the results of the "Class 1 consumables" centralized procurement were announced. Laparoscopic puncture devices were included in the subsequent procurement scope, and the procurement period would start from the implementation of the selection results and end on June 30, 2028. This centralized procurement model has significantly reduced product prices, and has raised higher requirements for enterprises' cost control capabilities and large-scale production capacity.
Technological innovation has become a key dimension for manufacturers to compete. The "Single-Use Laparoscopic Needle Insertion Device and Kit" launched by Yingtai (Suzhou) Medical Technology Co., Ltd. features features such as visual puncture, blunt head protection, serrated design to prevent slippage, and detachable design for convenient retrieval. This innovative design not only enhances the product performance but also strengthens the core competitiveness of the enterprise.
In the future, market competition will place greater emphasis on the integration of industrial chains and the construction of ecosystems. Multinational enterprises control the entire value chain from raw materials to end products through vertical integration; local enterprises, on the other hand, establish a collaborative innovation system involving industry, academia, research institutions and enterprises through horizontal cooperation. As technological innovation accelerates, industry standards improve and competition intensifies, enterprises with core technologies, large-scale production capabilities and good cost control will prevail in industry integration.